Electronic Data Capture (EDC) systems are the heartbeat of modern clinical trials. With most platforms now offered as Software-as-a-Service (SaaS), sponsors benefit from faster implementation, lower infrastructure costs, and improved accessibility for sites.

But SaaS comes with a hidden challenge: frequent vendor updates.
Most SaaS EDCs release 3–6 updates per year. Each update introduces potential risks: Unvalidated functions, broken workflows, or compliance gaps. For sponsors, this means you could pass an inspection one month, then fail the next, simply because of a vendor-driven change outside your control.

The Challenge of SaaS Validation

Unlike traditional on-premise systems, sponsors don’t control the update cycle for SaaS EDCs. This creates unique risks:

• Loss of validation state: Each update could invalidate your previous testing.
• Shared environments: Multi-tenant SaaS platforms make it harder to prove your specific environment is validated.
• Documentation gaps: Regulators may ask to see proof of validation that reflects every system change.

For sponsors, this means validation is no longer a one-time project — it’s a continuous responsibility.

Why Continuous Validation Matters

1. Real-time Compliance
   Continuous validation ensures every update is assessed automatically, keeping your system inspection-ready at all times.
2. Reduced Human Error
   Automation eliminates reliance on manual, document-heavy processes that are prone to mistakes.
3. Cost and Time Savings
   Instead of revalidating from scratch with each vendor release, continuous validation focuses only on impacted functions, reducing wasted effort.
4. Faster Adoption of New Features
   With confidence in your validation process, sponsors can adopt vendor updates quickly instead of delaying for fear of compliance gaps.

What Sponsors Should Do

• Adopt automated risk assessment tools to instantly evaluate update impact on critical functions.
• Integrate change control with vendor release cycles to ensure updates are validated before rollout.
• Implement continuous monitoring frameworks for real-time system performance and compliance indicators.
• Strengthen vendor management with SLAs, validation documentation, and regular audits.

The Future of EDC Validation

Regulators are increasingly supportive of risk-based validation approaches, encouraging sponsors to move beyond traditional, manual testing. Continuous validation isn’t just a compliance strategy — it’s a competitive advantage. Sponsors that adopt it gain:

• Higher-quality data
• Faster study timelines
• Lower compliance costs

Bottom Line for Sponsors

Your SaaS EDC is essential to trial success: but without continuous validation, every vendor update puts your study at risk. Sponsors that embrace automated, risk-based validation approaches stay compliant, protect data integrity, and keep their studies moving forward.

At Bioforum, we help sponsors implement continuous validation frameworks that align with SaaS release cycles and regulatory expectations.

Contact us to learn how we can safeguard your EDC systems without slowing your studies.